Patents by Inventor Ulf D. Landegren

Ulf D. Landegren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5759773
    Abstract: Nucleic acid sandwich hybridization assays are provided that incorporate one or a combination of background reduction steps. Those steps include use of a separate capture probe and separation from immobilized capture probes by cleavage and isolation. A very sensitive assay for RNA targets includes both of those steps, plus RNA binary probes, an RNA-directed RNA ligase and amplification by an RNA-directed RNA polymerase. Kits of reagents for performing assays according to this invention are also provided.
    Type: Grant
    Filed: February 24, 1995
    Date of Patent: June 2, 1998
    Assignee: The Public Health Research Institute of the City of New York, Inc.
    Inventors: Sanjay Tyagi, Fred R. Kramer, Paul M. Lizardi, Ulf D. Landegren, Herman J. Blok
  • Patent number: 5652107
    Abstract: There are provided nucleic acid hybridization assays for RNA targets using RNA binary probes and a ribozyme ligase that is a stringent RNA-directed RNA ligase. Preferred assays include exponential amplification for signal generation. Tetrahymena ribozyme ligase is a preferred ligase for use in this invention. It may be tethered to hold it close to the ligation junction. One assay according to this invention is a "tethered ligase chain reaction." Also provided are kits for performing assays according to the invention.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: July 29, 1997
    Assignee: The Public Health Research Institute of the City of New York, Inc.
    Inventors: Paul M. Lizardi, Sanjay Tyagi, Ulf D. Landegren, Fred R. Kramer, Jack W. Szostak
  • Patent number: 5599660
    Abstract: A method and preparation for the storage and delivery of purified reagents is disclosed. In one aspect, the preparation comprises an amount of a first wax carrier, the first wax carrier having a first melting point, and an amount of a first reagent, wherein first reagent is a substantially purified preparation of at least one biological or chemical reagent. The first wax carrier and the first reagent are combined to form a solid first reagent portion. The solid mixture is combined with a second reagent portion comprised of at least one biological or chemical reagent in an inactive form.
    Type: Grant
    Filed: December 2, 1994
    Date of Patent: February 4, 1997
    Assignee: Pharmacia Biotech Inc.
    Inventors: Rama P. Ramanujam, Brent A. Burdick, Ulf D. Landegren, Pierre Sevigny